DaVita HealthCare Partners Inc. (NYSE:DVA)‘s stock had its “hold” rating reiterated by analysts at KeyCorp in a report released on Monday.

Several other brokerages have also commented on DVA. J P Morgan Chase & Co lowered shares of DaVita HealthCare Partners from a “neutral” rating to an “underweight” rating in a research report on Monday, October 9th. Wolfe Research raised shares of DaVita HealthCare Partners from a “market perform” rating to an “outperform” rating in a research report on Monday, October 23rd. Royal Bank Of Canada dropped their price target on shares of DaVita HealthCare Partners from $64.00 to $60.00 and set a “sector perform” rating for the company in a research report on Wednesday, November 8th. TheStreet lowered shares of DaVita HealthCare Partners from a “b” rating to a “c+” rating in a research report on Wednesday, August 2nd. Finally, Zacks Investment Research raised shares of DaVita HealthCare Partners from a “sell” rating to a “hold” rating in a research report on Thursday, August 3rd. Four analysts have rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $63.00.

DaVita HealthCare Partners (NYSE DVA) opened at $54.66 on Monday. DaVita HealthCare Partners has a one year low of $52.51 and a one year high of $70.16. The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.35 and a current ratio of 1.40. The stock has a market cap of $10,405.85, a P/E ratio of 15.71, a P/E/G ratio of 11.08 and a beta of 0.98.

DaVita HealthCare Partners (NYSE:DVA) last issued its quarterly earnings results on Tuesday, November 7th. The company reported $0.81 EPS for the quarter, missing the consensus estimate of $0.94 by ($0.13). DaVita HealthCare Partners had a return on equity of 13.31% and a net margin of 3.40%. The company had revenue of $3.92 billion for the quarter, compared to analyst estimates of $3.91 billion. During the same period last year, the company posted $0.95 EPS. The business’s revenue for the quarter was up 5.2% on a year-over-year basis. research analysts forecast that DaVita HealthCare Partners will post 3.42 EPS for the current fiscal year.

DaVita HealthCare Partners announced that its board has initiated a stock repurchase program on Tuesday, October 10th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its shares are undervalued.

WARNING: “KeyCorp Reiterates “Hold” Rating for DaVita HealthCare Partners Inc. (DVA)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/11/15/keycorp-reiterates-hold-rating-for-davita-healthcare-partners-inc-dva.html.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in DVA. Thrivent Financial For Lutherans grew its holdings in DaVita HealthCare Partners by 4.4% during the 1st quarter. Thrivent Financial For Lutherans now owns 5,730 shares of the company’s stock valued at $389,000 after purchasing an additional 240 shares in the last quarter. Mn Services Vermogensbeheer B.V. grew its holdings in DaVita HealthCare Partners by 491.6% during the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 25,274 shares of the company’s stock valued at $1,637,000 after purchasing an additional 21,002 shares in the last quarter. Eqis Capital Management Inc. grew its holdings in DaVita HealthCare Partners by 2.2% during the 2nd quarter. Eqis Capital Management Inc. now owns 4,600 shares of the company’s stock valued at $298,000 after purchasing an additional 100 shares in the last quarter. Founders Capital Management LLC grew its holdings in DaVita HealthCare Partners by 0.6% during the 2nd quarter. Founders Capital Management LLC now owns 93,824 shares of the company’s stock valued at $6,076,000 after purchasing an additional 520 shares in the last quarter. Finally, PGGM Investments acquired a new stake in DaVita HealthCare Partners during the 2nd quarter valued at $28,598,000. 84.73% of the stock is owned by institutional investors and hedge funds.

About DaVita HealthCare Partners

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Analyst Recommendations for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Stock Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related stocks with our FREE daily email newsletter.